Interpace Biosciences Inc

IDXG ·Healthcare, Medical Devices, United States

SEC Filings

Form	Filed	Description
10-Q	May 12, 2026	10-Q
10-K/A	Apr 30, 2026	10-K/A
8-K	Apr 1, 2026	8-K
10-K	Mar 30, 2026	10-K
4	Feb 17, 2026	4
4	Feb 4, 2026	4
8-K	Jan 20, 2026	8-K
8-K	Dec 3, 2025	8-K
8-K	Nov 12, 2025	8-K
10-Q	Nov 12, 2025	10-Q
8-K	Aug 8, 2025	8-K
10-Q	Aug 7, 2025	10-Q
10-Q	May 8, 2025	10-Q
8-K	May 8, 2025	8-K
8-K	May 1, 2025	8-K
10-K/A	Apr 28, 2025
4	Apr 25, 2025
10-K	Mar 31, 2025
8-K	Mar 6, 2025
SCHEDULE 13G/A	Feb 14, 2025
SCHEDULE 13G/A	Feb 14, 2025
8-K	Jan 27, 2025
8-K	Jan 21, 2025
8-K	Jan 10, 2025
8-K	Nov 13, 2024

← Newer Page 2 of 44 · 1094 filings Older →